Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Abemaciclib|DRUG: Abemaciclib|DRUG: Abemaciclib|DRUG: Abemaciclib
Sponsor: University of Illinois at Chicago